<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">27974562</PMID><DateCompleted><Year>2017</Year><Month>05</Month><Day>29</Day></DateCompleted><DateRevised><Year>2019</Year><Month>03</Month><Day>29</Day></DateRevised><Article PubModel="Electronic-Print"><Journal><ISSN IssnType="Electronic">1098-5514</ISSN><JournalIssue CitedMedium="Internet"><Volume>91</Volume><Issue>5</Issue><PubDate><Year>2017</Year><Month>Mar</Month><Day>01</Day></PubDate></JournalIssue><Title>Journal of virology</Title><ISOAbbreviation>J Virol</ISOAbbreviation></Journal><ArticleTitle><i>In Vivo</i> Imaging with Bioluminescent Enterovirus 71 Allows for Real-Time Visualization of Tissue Tropism and Viral Spread.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">e01759-16</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1128/JVI.01759-16</ELocationID><Abstract><AbstractText>Hand, foot, and mouth disease (HFMD) is a reemerging illness caused by a variety of enteroviruses. The main causative agents are enterovirus 71 (EV71), coxsackievirus A16 (CVA16), and, most recently, coxsackievirus A6 (CVA6). Enterovirus infections can vary from asymptomatic infections to those with a mild fever and blisters on infected individuals' hands, feet, and throats to infections with severe neurological complications. Viral persistence for weeks postinfection (wpi) has also been documented by the demonstration of virus in children's stools. However, little is known about disease progression, viral spread, and tissue tropism of these viruses. These types of studies are limited because many recently developed mouse models mimic the severe neurological complications that occur in a small percentage of enterovirus infections. In the present study, we documented real-time EV71 infection in two different mouse strains by the use of <i>in vivo</i> imaging. Infection of BALB/c mice with a bioluminescent mouse-adapted EV71 construct (mEV71-NLuc) resulted in a lack of clinical signs of disease but in relatively high viral replication, as visualized by luminescence, for 2 wpi. In contrast, mEV71-NLuc infection of AG129 mice (alpha/beta and gamma interferon receptor deficient) showed rapid spread and long-term persistence of the virus in the brain. Interestingly, AG129 mice that survived infection maintained luminescence in the brain for up to 8 wpi. The results we present here will allow future studies on EV71 antiviral drug susceptibility, vaccine efficacy, transmissibility, and pathogenesis. <b>IMPORTANCE</b> We report here that a stable full-length enterovirus 71 (EV71) reporter construct was used to visualize real-time viral spread in AG129 and BALB/c mice. To our knowledge, this is the first report of <i>in vivo</i> imaging of infection with any member of the <i>Picornaviridae</i> family. The nanoluciferase (NLuc) gene, one of the smallest luciferase genes currently available, was shown to be stable in the EV71 genome for eight passages on rhabdomyosarcoma cells. Real-time visualization of EV71 infection in mice identified areas of tropism that would have been missed by traditional methods, including full characterization of EV71 replication in BALB/c mice. Additionally, the bioluminescent construct allowed for increased speed and sensitivity of cell culture assays and will allow future studies involving various degrees of enterovirus infection in mice, not just severe infections. Our data suggest that interferon plays an important role in controlling EV71 infection in the central nervous system of mice.</AbstractText><CopyrightInformation>Copyright &#xa9; 2017 American Society for Microbiology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Caine</LastName><ForeName>Elizabeth A</ForeName><Initials>EA</Initials><AffiliationInfo><Affiliation>Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, Wisconsin, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Osorio</LastName><ForeName>Jorge E</ForeName><Initials>JE</Initials><AffiliationInfo><Affiliation>Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, Wisconsin, USA jorge.osorio@wisc.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>T32 AI055397</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>02</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Virol</MedlineTA><NlmUniqueID>0113724</NlmUniqueID><ISSNLinking>0022-538X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="N">Enterovirus Infections</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008807" MajorTopicYN="N">Mice, Inbred BALB C</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009928" MajorTopicYN="N">Organ Specificity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019562" MajorTopicYN="N">Viral Load</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="Y">Virus Replication</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051598" MajorTopicYN="N">Whole Body Imaging</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">enterovirus 71</Keyword><Keyword MajorTopicYN="N">in vivo imaging</Keyword><Keyword MajorTopicYN="N">mouse models</Keyword><Keyword MajorTopicYN="N">nanoluciferase</Keyword><Keyword MajorTopicYN="N">pathogenesis</Keyword><Keyword MajorTopicYN="N">tissue tropism</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>9</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>12</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>12</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>5</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>12</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2017</Year><Month>8</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27974562</ArticleId><ArticleId IdType="pmc">PMC5309956</ArticleId><ArticleId IdType="doi">10.1128/JVI.01759-16</ArticleId><ArticleId IdType="pii">JVI.01759-16</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Solomon T, Lewthwaite P, Perera D, Cardosa MJ, McMinn P, Ooi MH. 2010. Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect Dis 10:778&#x2013;790. doi:10.1016/S1473-3099(10)70194-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(10)70194-8</ArticleId><ArticleId IdType="pubmed">20961813</ArticleId></ArticleIdList></Reference><Reference><Citation>Nassef C, Ziemer C, Morrell DS. 2015. Hand-foot-and-mouth disease: a new look at a classic viral rash. Curr Opin Pediatr 27:486&#x2013;491. doi:10.1097/MOP.0000000000000246.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MOP.0000000000000246</ArticleId><ArticleId IdType="pubmed">26087425</ArticleId></ArticleIdList></Reference><Reference><Citation>Khetsuriani N, Lamonte-Fowlkes A, Oberste MS, Pallansch MA, Centers for Disease Control and Prevention. 2006. Enterovirus surveillance&#x2014;United States, 1970&#x2013;2005. MMWR Surveill Summ 55:1&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">16971890</ArticleId></ArticleIdList></Reference><Reference><Citation>Osterback R, Vuorinen T, Linna M, Susi P, Hyypia T, Waris M. 2009. Coxsackievirus A6 and hand, foot, and mouth disease, Finland. Emerg Infect Dis 15:1485&#x2013;1488. doi:10.3201/eid1509.090438.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid1509.090438</ArticleId><ArticleId IdType="pmc">PMC2819858</ArticleId><ArticleId IdType="pubmed">19788821</ArticleId></ArticleIdList></Reference><Reference><Citation>Montes M, Artieda J, Pineiro LD, Gastesi M, Diez-Nieves I, Cilla G. 2013. Hand, foot, and mouth disease outbreak and coxsackievirus A6, northern Spain, 2011. Emerg Infect Dis 19:676&#x2013;678. doi:10.3201/eid1904.121589.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid1904.121589</ArticleId><ArticleId IdType="pmc">PMC3647425</ArticleId><ArticleId IdType="pubmed">23751014</ArticleId></ArticleIdList></Reference><Reference><Citation>Han J, Ma XJ, Wan JF, Liu YH, Han YL, Chen C, Tian C, Gao C, Wang M, Dong XP. 2010. Long persistence of EV71 specific nucleotides in respiratory and feces samples of the patients with hand-foot-mouth disease after recovery. BMC Infect Dis 10:178. doi:10.1186/1471-2334-10-178.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2334-10-178</ArticleId><ArticleId IdType="pmc">PMC2895604</ArticleId><ArticleId IdType="pubmed">20565813</ArticleId></ArticleIdList></Reference><Reference><Citation>Witso E, Palacios G, Ronningen KS, Cinek O, Janowitz D, Rewers M, Grinde B, Lipkin WI. 2007. Asymptomatic circulation of HEV71 in Norway. Virus Res 123:19&#x2013;29. doi:10.1016/j.virusres.2006.07.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2006.07.015</ArticleId><ArticleId IdType="pubmed">16965832</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang LY, Tsao KC, Hsia SH, Shih SR, Huang CG, Chan WK, Hsu KH, Fang TY, Huang YC, Lin TY. 2004. Transmission and clinical features of enterovirus 71 infections in household contacts in Taiwan. JAMA 291:222&#x2013;227. doi:10.1001/jama.291.2.222.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.291.2.222</ArticleId><ArticleId IdType="pubmed">14722149</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang YF, Yu CK. 2014. Animal models of enterovirus 71 infection: applications and limitations. J Biomed Sci 21:31. doi:10.1186/1423-0127-21-31.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1423-0127-21-31</ArticleId><ArticleId IdType="pmc">PMC4013435</ArticleId><ArticleId IdType="pubmed">24742252</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujii K, Nagata N, Sato Y, Ong KC, Wong KT, Yamayoshi S, Shimanuki M, Shitara H, Taya C, Koike S. 2013. Transgenic mouse model for the study of enterovirus 71 neuropathogenesis. Proc Natl Acad Sci U S A 110:14753&#x2013;14758. doi:10.1073/pnas.1217563110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1217563110</ArticleId><ArticleId IdType="pmc">PMC3767555</ArticleId><ArticleId IdType="pubmed">23959904</ArticleId></ArticleIdList></Reference><Reference><Citation>Khong WX, Yan B, Yeo H, Tan EL, Lee JJ, Ng JK, Chow VT, Alonso S. 2012. A non-mouse-adapted enterovirus 71 (EV71) strain exhibits neurotropism, causing neurological manifestations in a novel mouse model of EV71 infection. J Virol 86:2121&#x2013;2131. doi:10.1128/JVI.06103-11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.06103-11</ArticleId><ArticleId IdType="pmc">PMC3302383</ArticleId><ArticleId IdType="pubmed">22130542</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W, Duo J, Liu J, Ma C, Zhang L, Wei Q, Qin C. 2011. A mouse muscle-adapted enterovirus 71 strain with increased virulence in mice. Microbes Infect 13:862&#x2013;870. doi:10.1016/j.micinf.2011.04.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.micinf.2011.04.004</ArticleId><ArticleId IdType="pubmed">21612764</ArticleId></ArticleIdList></Reference><Reference><Citation>Caine EA, Fuchs J, Das SC, Partidos CD, Osorio JE. 2015. Efficacy of a trivalent hand, foot, and mouth disease vaccine against enterovirus 71 and coxsackieviruses A16 and A6 in mice. Viruses 7:5919&#x2013;5932. doi:10.3390/v7112916.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v7112916</ArticleId><ArticleId IdType="pmc">PMC4664989</ArticleId><ArticleId IdType="pubmed">26593938</ArticleId></ArticleIdList></Reference><Reference><Citation>Caine EA, Partidos CD, Santangelo JD, Osorio JE. 2013. Adaptation of enterovirus 71 to adult interferon deficient mice. PLoS One 8:e59501. doi:10.1371/journal.pone.0059501.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0059501</ArticleId><ArticleId IdType="pmc">PMC3602422</ArticleId><ArticleId IdType="pubmed">23527208</ArticleId></ArticleIdList></Reference><Reference><Citation>Falendysz EA, Londono-Navas AM, Meteyer CU, Pussini N, Lopera JG, Osorio JE, Rocke TE. 2014. Evaluation of monkeypox virus infection of black-tailed prairie dogs (Cynomys ludovicianus) using in vivo bioluminescent imaging. J Wildl Dis 50:524&#x2013;536. doi:10.7589/2013-07-171.</Citation><ArticleIdList><ArticleId IdType="doi">10.7589/2013-07-171</ArticleId><ArticleId IdType="pmc">PMC4636010</ArticleId><ArticleId IdType="pubmed">24779460</ArticleId></ArticleIdList></Reference><Reference><Citation>Schoggins JW, Dorner M, Feulner M, Imanaka N, Murphy MY, Ploss A, Rice CM. 2012. Dengue reporter viruses reveal viral dynamics in interferon receptor-deficient mice and sensitivity to interferon effectors in vitro. Proc Natl Acad Sci U S A 109:14610&#x2013;14615. doi:10.1073/pnas.1212379109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1212379109</ArticleId><ArticleId IdType="pmc">PMC3437900</ArticleId><ArticleId IdType="pubmed">22908290</ArticleId></ArticleIdList></Reference><Reference><Citation>Tran V, Moser LA, Poole DS, Mehle A. 2013. Highly sensitive real-time in vivo imaging of an influenza reporter virus reveals dynamics of replication and spread. J Virol 87:13321&#x2013;13329. doi:10.1128/JVI.02381-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02381-13</ArticleId><ArticleId IdType="pmc">PMC3838222</ArticleId><ArticleId IdType="pubmed">24089552</ArticleId></ArticleIdList></Reference><Reference><Citation>Luker GD, Bardill JP, Prior JL, Pica CM, Piwnica-Worms D, Leib DA. 2002. Noninvasive bioluminescence imaging of herpes simplex virus type 1 infection and therapy in living mice. J Virol 76:12149&#x2013;12161. doi:10.1128/JVI.76.23.12149-12161.2002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.76.23.12149-12161.2002</ArticleId><ArticleId IdType="pmc">PMC136903</ArticleId><ArticleId IdType="pubmed">12414955</ArticleId></ArticleIdList></Reference><Reference><Citation>Song Y, Paul AV, Wimmer E. 2012. Evolution of poliovirus defective interfering particles expressing Gaussia luciferase. J Virol 86:1999&#x2013;2010. doi:10.1128/JVI.05871-11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.05871-11</ArticleId><ArticleId IdType="pmc">PMC3302396</ArticleId><ArticleId IdType="pubmed">22156535</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Wang C, Mueller S, Paul AV, Wimmer E, Jiang P. 2010. Direct interaction between two viral proteins, the nonstructural protein 2C and the capsid protein VP3, is required for enterovirus morphogenesis. PLoS Pathog 6:e1001066. doi:10.1371/journal.ppat.1001066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1001066</ArticleId><ArticleId IdType="pmc">PMC2928791</ArticleId><ArticleId IdType="pubmed">20865167</ArticleId></ArticleIdList></Reference><Reference><Citation>Shang B, Deng C, Ye H, Xu W, Yuan Z, Shi PY, Zhang B. 2013. Development and characterization of a stable eGFP enterovirus 71 for antiviral screening. Antiviral Res 97:198&#x2013;205. doi:10.1016/j.antiviral.2012.12.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2012.12.010</ArticleId><ArticleId IdType="pubmed">23267829</ArticleId></ArticleIdList></Reference><Reference><Citation>Hall MP, Unch J, Binkowski BF, Valley MP, Butler BL, Wood MG, Otto P, Zimmerman K, Vidugiris G, Machleidt T, Robers MB, Benink HA, Eggers CT, Slater MR, Meisenheimer PL, Klaubert DH, Fan F, Encell LP, Wood KV. 2012. Engineered luciferase reporter from a deep sea shrimp utilizing a novel imidazopyrazinone substrate. ACS Chem Biol 7:1848&#x2013;1857. doi:10.1021/cb3002478.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/cb3002478</ArticleId><ArticleId IdType="pmc">PMC3501149</ArticleId><ArticleId IdType="pubmed">22894855</ArticleId></ArticleIdList></Reference><Reference><Citation>Caine EA, Moncla LH, Ronderos MD, Friedrich TC, Osorio JE. 2016. A single mutation in the VP1 of enterovirus 71 is responsible for increased virulence and neurotropism in adult interferon deficient mice. J Virol 90:8592&#x2013;8604. doi:10.1128/JVI.01370-16.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01370-16</ArticleId><ArticleId IdType="pmc">PMC5021399</ArticleId><ArticleId IdType="pubmed">27440896</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaini Z, Phuektes P, McMinn P. 2012. Mouse adaptation of a sub-genogroup B5 strain of human enterovirus 71 is associated with a novel lysine to glutamic acid substitution at position 244 in protein VP1. Virus Res 167:86&#x2013;96. doi:10.1016/j.virusres.2012.04.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2012.04.009</ArticleId><ArticleId IdType="pubmed">22575826</ArticleId></ArticleIdList></Reference><Reference><Citation>Karlsson EA, Meliopoulos VA, Savage C, Livingston B, Mehle A, Schultz-Cherry S. 2015. Visualizing real-time influenza virus infection, transmission and protection in ferrets. Nat Commun 6:6378. doi:10.1038/ncomms7378.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms7378</ArticleId><ArticleId IdType="pmc">PMC4366512</ArticleId><ArticleId IdType="pubmed">25744559</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu LL, Shan C, Deng CL, Li XD, Shang BD, Ye HQ, Liu SQ, Yuan ZM, Wang QY, Shi PY, Zhang B. 2015. Development of a stable Gaussia luciferase enterovirus 71 reporter virus. J Virol Methods 219:62&#x2013;66. doi:10.1016/j.jviromet.2015.03.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jviromet.2015.03.020</ArticleId><ArticleId IdType="pubmed">25843263</ArticleId></ArticleIdList></Reference><Reference><Citation>Julien J, Leparc-Goffart I, Lina B, Fuchs F, Foray S, Janatova I, Aymard M, Kopecka H. 1999. Postpolio syndrome: poliovirus persistence is involved in the pathogenesis. J Neurol 246:472&#x2013;476. doi:10.1007/s004150050386.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s004150050386</ArticleId><ArticleId IdType="pubmed">10431774</ArticleId></ArticleIdList></Reference><Reference><Citation>Colbere-Garapin F, Christodoulou C, Crainic R, Pelletier I. 1989. Persistent poliovirus infection of human neuroblastoma cells. Proc Natl Acad Sci U S A 86:7590&#x2013;7594. doi:10.1073/pnas.86.19.7590.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.86.19.7590</ArticleId><ArticleId IdType="pmc">PMC298111</ArticleId><ArticleId IdType="pubmed">2552448</ArticleId></ArticleIdList></Reference><Reference><Citation>Pavio N, Buc-Caron MH, Colbere-Garapin F. 1996. Persistent poliovirus infection of human fetal brain cells. J Virol 70:6395&#x2013;6401.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC190667</ArticleId><ArticleId IdType="pubmed">8709269</ArticleId></ArticleIdList></Reference><Reference><Citation>Destombes J, Couderc T, Thiesson D, Girard S, Wilt SG, Blondel B. 1997. Persistent poliovirus infection in mouse motoneurons. J Virol 71:1621&#x2013;1628.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC191220</ArticleId><ArticleId IdType="pubmed">8995689</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim KS, Tracy S, Tapprich W, Bailey J, Lee CK, Kim K, Barry WH, Chapman NM. 2005. 5&#x2032;-terminal deletions occur in coxsackievirus B3 during replication in murine hearts and cardiac myocyte cultures and correlate with encapsidation of negative-strand viral RNA. J Virol 79:7024&#x2013;7041. doi:10.1128/JVI.79.11.7024-7041.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.79.11.7024-7041.2005</ArticleId><ArticleId IdType="pmc">PMC1112132</ArticleId><ArticleId IdType="pubmed">15890942</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen FH, Tsai CC, Wang LC, Chang KC, Tung YY, Su IJ, Chen SH. 2013. Enterovirus 71 infection increases expression of interferon-gamma-inducible protein 10 which protects mice by reducing viral burden in multiple tissues. J Gen Virol 94:1019&#x2013;1027. doi:10.1099/vir.0.046383-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.046383-0</ArticleId><ArticleId IdType="pubmed">23288420</ArticleId></ArticleIdList></Reference><Reference><Citation>Ida-Hosonuma M, Iwasaki T, Yoshikawa T, Nagata N, Sato Y, Sata T, Yoneyama M, Fujita T, Taya C, Yonekawa H, Koike S. 2005. The alpha/beta interferon response controls tissue tropism and pathogenicity of poliovirus. J Virol 79:4460&#x2013;4469. doi:10.1128/JVI.79.7.4460-4469.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.79.7.4460-4469.2005</ArticleId><ArticleId IdType="pmc">PMC1061561</ArticleId><ArticleId IdType="pubmed">15767446</ArticleId></ArticleIdList></Reference><Reference><Citation>Daniels BP, Klein RS. 2015. Knocking on closed doors: host interferons dynamically regulate blood-brain barrier function during viral infections of the central nervous system. PLoS Pathog 11:e1005096. doi:10.1371/journal.ppat.1005096.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1005096</ArticleId><ArticleId IdType="pmc">PMC4574746</ArticleId><ArticleId IdType="pubmed">26379171</ArticleId></ArticleIdList></Reference><Reference><Citation>Rotbart HA. 1995. Enteroviral infections of the central nervous system. Clin Infect Dis 20:971&#x2013;981. doi:10.1093/clinids/20.4.971.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/clinids/20.4.971</ArticleId><ArticleId IdType="pubmed">7795102</ArticleId></ArticleIdList></Reference><Reference><Citation>de Vries HE, Kuiper J, de Boer AG, Van Berkel TJ, Breimer DD. 1997. The blood-brain barrier in neuroinflammatory diseases. Pharmacol Rev 49:143&#x2013;155.</Citation><ArticleIdList><ArticleId IdType="pubmed">9228664</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan SH, Ong KC, Wong KT. 2014. Enterovirus 71 can directly infect the brainstem via cranial nerves and infection can be ameliorated by passive immunization. J Neuropathol Exp Neurol 73:999&#x2013;1008. doi:10.1097/NEN.0000000000000122.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/NEN.0000000000000122</ArticleId><ArticleId IdType="pubmed">25289894</ArticleId></ArticleIdList></Reference><Reference><Citation>National Research Council. 2011. Guide for the care and use of laboratory animals, 8th ed National Academies Press, Washington, DC.</Citation></Reference><Reference><Citation>Quan J, Tian J. 2011. Circular polymerase extension cloning for high-throughput cloning of complex and combinatorial DNA libraries. Nat Protoc 6:242&#x2013;251. doi:10.1038/nprot.2010.181.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nprot.2010.181</ArticleId><ArticleId IdType="pubmed">21293463</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosner B. 2011. Fundamentals of biostatistics, 7th ed Brooks/Cole, Cengage Learning, Boston, MA.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>